Sun Pharmaceuticals - CCI’s Conditional Nod Lifts Overhang; Event Update :: Edelweiss

Please Share::

�� India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details ��

��

-->

The Competition Commission of India (CCI)  has given its conditional nod to the proposed merger of Sun Pharma (SUNP) and Ranbaxy Laboratories (RBXY). As widely anticipated, CCI has asked for divestiture of certain brands in which the combined entity would have created a monopolistic situation in the Indian Pharma Market (IPM). However, small quantum of the divestiture (

Conditional nod…INR500mn worth products to be divested

SUNP-RBXY need to divest seven brands (SUNP: 2, RBXY: 5) within the next 6 months. As per AIOCD MAT Oct’14, total sales of the brands is INR480mn (<0 .3="" 1="" 2015.="" 37="" a="" and="" approvals="" awaits="" be="" before="" believe="" but="" by="" can="" cci.="" cci="" close="" combined="" come="" completed="" contingent="" court="" deal="" divestment="" divestments="" earnings="" entity="" expect="" final="" for="" from:="" ftc="" fy14="" haryana="" high="" highlighted="" i="" ii="" iii="" impact="" in="" is="" it="" march="" matter="" months.="" negligible.="" nod="" noting="" now="" number="" of="" on="" only="" p="" post="" process="" products="" punjab="" rbxy="" s="" sales="" significantly="" six="" smaller="" stipulated="" submissions="" sunp="" table="" than="" that="" the="" their="" these="" through="" time="" timeline="" to="" us.="" we="" will="" worth="">